{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Crohn\u2019s disease", "NLR Family Pyrin Domain Containing 3", "NLRP3", "cancer", "inflammasome", "inflammation", "inflammatory bowel disease", "medicinal plants", "phytochemicals", "ulcerative colitis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37367886", "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "06"}], "Language": ["eng"], "ELocationID": ["728", "10.3390/metabo13060728"], "Journal": {"ISSN": "2218-1989", "JournalIssue": {"Volume": "13", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "06"}}, "Title": "Metabolites", "ISOAbbreviation": "Metabolites"}, "ArticleTitle": "Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review.", "Abstract": {"AbstractText": ["Ongoing research explores the underlying causes of ulcerative colitis and Crohn's disease. Many experts suggest that dysbiosis in the gut microbiota and genetic, immunological, and environmental factors play significant roles. The term \"microbiota\" pertains to the collective community of microorganisms, including bacteria, viruses, and fungi, that reside within the gastrointestinal tract, with a particular emphasis on the colon. When there is an imbalance or disruption in the composition of the gut microbiota, it is referred to as dysbiosis. Dysbiosis can trigger inflammation in the intestinal cells and disrupt the innate immune system, leading to oxidative stress, redox signaling, electrophilic stress, and inflammation. The Nod-like Receptor (NLR) Family Pyrin Domain Containing 3 (NLRP3) inflammasome, a key regulator found in immunological and epithelial cells, is crucial in inducing inflammatory diseases, promoting immune responses to the gut microbiota, and regulating the integrity of the intestinal epithelium. Its downstream effectors include caspase-1 and interleukin (IL)-1\u03b2. The present study investigated the therapeutic potential of 13 medicinal plants, such as <i>Litsea cubeba</i>, <i>Artemisia anomala</i>, <i>Piper nigrum</i>, <i>Morus macroura</i>, and <i>Agrimonia pilosa</i>, and 29 phytocompounds such as artemisitene, morroniside, protopine, ferulic acid, quercetin, picroside II, and hydroxytyrosol on in vitro and in vivo models of inflammatory bowel diseases (IBD), with a focus on their effects on the NLRP3 inflammasome. The observed effects of these treatments included reductions in IL-1\u03b2, tumor necrosis factor-alpha, IL-6, interferon-gamma, and caspase levels, and increased expression of antioxidant enzymes, IL-4, and IL-10, as well as regulation of gut microbiota. These effects could potentially provide substantial advantages in treating IBD with few or no adverse effects as caused by synthetic anti-inflammatory and immunomodulated drugs. However, additional research is necessary to validate these findings clinically and to develop effective treatments that can benefit individuals who suffer from these diseases."]}, "AuthorList": [{"Identifier": ["0000-0002-4143-4302"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Systems Integration Pharmacology, Clinical & Regulatory Science, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal."}], "LastName": "Direito", "ForeName": "Rosa", "Initials": "R"}, {"Identifier": ["0000-0002-5035-876X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Nutrition, School of Food and Technology of Mar\u00edlia (FATEC), Avenida Castro Alves, 62, Mar\u00edlia 17500-000, S\u00e3o Paulo, Brazil."}], "LastName": "Barbalho", "ForeName": "Sandra Maria", "Initials": "SM"}, {"Identifier": ["0000-0002-1561-6858"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Systems Integration Pharmacology, Clinical & Regulatory Science, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal."}], "LastName": "Figueira", "ForeName": "Maria Eduardo", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "Minniti", "ForeName": "Giulia", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "de Carvalho", "ForeName": "Gabriel Magno", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "de Oliveira Zanuso", "ForeName": "B\u00e1rbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "de Oliveira Dos Santos", "ForeName": "Ana Rita", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "de G\u00f3es Corr\u00eaa", "ForeName": "Nat\u00e1lia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Mar\u00edlia (FAMEMA), Avenida Monte Carmelo, 800, Mar\u00edlia 17519-030, S\u00e3o Paulo, Brazil."}], "LastName": "Rodrigues", "ForeName": "Vict\u00f3ria Dogani", "Initials": "VD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "de Alvares Goulart", "ForeName": "Ricardo", "Initials": "R"}, {"Identifier": ["0000-0002-9930-9694"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Nutrition, School of Food and Technology of Mar\u00edlia (FATEC), Avenida Castro Alves, 62, Mar\u00edlia 17500-000, S\u00e3o Paulo, Brazil."}], "LastName": "Guiguer", "ForeName": "Elen Landgraf", "Initials": "EL"}, {"Identifier": ["0000-0002-5716-2444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}], "LastName": "Ara\u00fajo", "ForeName": "Adriano Cressoni", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Department, School of Medicine, Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto (FAMERP), Avenida Brigadeiro Faria Lima, 5416, S\u00e3o Jos\u00e9 do Rio Preto 15090-000, S\u00e3o Paulo, Brazil."}], "LastName": "Bosso", "ForeName": "Henrique", "Initials": "H"}, {"Identifier": ["0000-0003-3159-0982"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, University of Mar\u00edlia (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Mar\u00edlia 17525-902, S\u00e3o Paulo, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Mar\u00edlia (FAMEMA), Avenida Monte Carmelo, 800, Mar\u00edlia 17519-030, S\u00e3o Paulo, Brazil."}], "LastName": "Fornari Laurindo", "ForeName": "Lucas", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Metabolites", "NlmUniqueID": "101578790", "ISSNLinking": "2218-1989"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sharma V., Gautam D.N.S., Radu A.F., Behl T., Bungau S.G., Vesa C.M. Reviewing the Traditional/Modern Uses, Phytochemistry, Essential Oils/Extracts and Pharmacology of Embelia ribes Burm. Antioxidants. 2022;11:1359. doi: 10.3390/antiox11071359.", "ArticleIdList": ["10.3390/antiox11071359", "PMC9311956", "35883850"]}, {"Citation": "Dai W., Long L., Wang X., Li S., Xu H. Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease. Chin. Med. 2022;17:53. doi: 10.1186/s13020-022-00611-w.", "ArticleIdList": ["10.1186/s13020-022-00611-w", "PMC9047385", "35484567"]}, {"Citation": "Baradaran Rahimi V., Rahmanian Devin P., Askari V.R. Boswellia serrata inhibits LPS-induced cardiotoxicity in H9c2 cells: Investigating role of anti-inflammatory and antioxidant effects. Toxicon. 2023;229:107132. doi: 10.1016/j.toxicon.2023.107132.", "ArticleIdList": ["10.1016/j.toxicon.2023.107132", "37086900"]}, {"Citation": "Pereira R.B., Rahali F.Z., Nehme R., Falleh H., Jemaa M.B., Sellami I.H., Ksouri R., Bouhallab S., Ceciliani F., Abdennebi-Najar L., et al. Anti-inflammatory activity of essential oils from Tunisian aromatic and medicinal plants and their major constituents in THP-1 macrophages. Food Res. Int. 2023;167:112678. doi: 10.1016/j.foodres.2023.112678.", "ArticleIdList": ["10.1016/j.foodres.2023.112678", "37087210"]}, {"Citation": "Sardou H.S., Vosough P.R., Abbaspour M., Akhgari A., Sathyapalan T., Sahebkar A. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease. Inflammopharmacology. 2023;31:1095\u20131105. doi: 10.1007/s10787-023-01140-0.", "ArticleIdList": ["10.1007/s10787-023-01140-0", "36757584"]}, {"Citation": "Laurindo L.F., de Maio M.C., Minniti G., de G\u00f3es Corr\u00eaa N., Barbalho S.M., Quesada K., Guiguer E.L., Sloan K.P., Detregiachi C.R.P., Ara\u00fajo A.C., et al. Effects of Medicinal Plants and Phytochemicals in Nrf2 Pathways during Inflammatory Bowel Diseases and Related Colorectal Cancer: A Comprehensive Review. Metabolites. 2023;13:243. doi: 10.3390/metabo13020243.", "ArticleIdList": ["10.3390/metabo13020243", "PMC9966918", "36837862"]}, {"Citation": "Rogler G., Singh A., Kavanaugh A., Rubin D.T. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021;161:1118\u20131132. doi: 10.1053/j.gastro.2021.07.042.", "ArticleIdList": ["10.1053/j.gastro.2021.07.042", "PMC8564770", "34358489"]}, {"Citation": "Haneishi Y., Furuya Y., Hasegawa M., Picarelli A., Rossi M., Miyamoto J. Inflammatory Bowel Diseases and Gut Microbiota. Int. J. Mol. Sci. 2023;24:3817. doi: 10.3390/ijms24043817.", "ArticleIdList": ["10.3390/ijms24043817", "PMC9958622", "36835245"]}, {"Citation": "Felice C., Dal Buono A., Gabbiadini R., Rattazzi M., Armuzzi A. Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications. Int. J. Mol. Sci. 2023;24:3957. doi: 10.3390/ijms24043957.", "ArticleIdList": ["10.3390/ijms24043957", "PMC9968229", "36835369"]}, {"Citation": "Zhen Y., Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front. Immunol. 2019;10:276. doi: 10.3389/fimmu.2019.00276.", "ArticleIdList": ["10.3389/fimmu.2019.00276", "PMC6403142", "30873162"]}, {"Citation": "Shao B.Z., Xu Z.Q., Han B.Z., Su D.F., Liu C. NLRP3 inflammasome and its inhibitors: A review. Front. Pharmacol. 2015;6:262. doi: 10.3389/fphar.2015.00262.", "ArticleIdList": ["10.3389/fphar.2015.00262", "PMC4633676", "26594174"]}, {"Citation": "Koca-\u00dcnsal R.B., \u015eehirli A., Say\u0131ner S., Aksoy U. Relationship of NLRP3 inflammasome with periodontal, endodontic and related systemic diseases. Mol. Biol. Rep. 2022;49:11123\u201311132. doi: 10.1007/s11033-022-07894-0.", "ArticleIdList": ["10.1007/s11033-022-07894-0", "36107371"]}, {"Citation": "Laurindo L.F., Santos A., Carvalho A.C.A., Bechara M.D., Guiguer E.L., Goulart R.A., Vargas Sinatora R., Ara\u00fajo A.C., Barbalho S.M. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites. 2023;13:96. doi: 10.3390/metabo13010096.", "ArticleIdList": ["10.3390/metabo13010096", "PMC9862976", "36677021"]}, {"Citation": "Baethge C., Goldbeck-Wood S., Mertens S. SANRA\u2014A scale for the quality assessment of narrative review articles. Res. Integr. Peer Rev. 2019;4:5. doi: 10.1186/s41073-019-0064-8.", "ArticleIdList": ["10.1186/s41073-019-0064-8", "PMC6434870", "30962953"]}, {"Citation": "Dai Y., Lu Q., Li P., Zhu J., Jiang J., Zhao T., Hu Y., Ding K., Zhao M. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-\u03baB signaling pathway. J. Ethnopharmacol. 2023;300:115690. doi: 10.1016/j.jep.2022.115690.", "ArticleIdList": ["10.1016/j.jep.2022.115690", "36075274"]}, {"Citation": "Wong W.T., Wu C.H., Li L.H., Hung D.Y., Chiu H.W., Hsu H.T., Ho C.L., Chernikov O.V., Cheng S.M., Yang S.P., et al. The leaves of the seasoning plant Litsea cubeba inhibit the NLRP3 inflammasome and ameliorate dextran sulfate sodium-induced colitis in mice. Front. Nutr. 2022;9:871325. doi: 10.3389/fnut.2022.871325.", "ArticleIdList": ["10.3389/fnut.2022.871325", "PMC9363825", "35967819"]}, {"Citation": "Hong F., Zhao M., Xue L.L., Ma X., Liu L., Cai X.Y., Zhang R.J., Li N., Wang L., Ni H.F., et al. The ethanolic extract of Artemisia anomala exerts anti-inflammatory effects via inhibition of NLRP3 inflammasome. Phytomedicine. 2022;102:154163. doi: 10.1016/j.phymed.2022.154163.", "ArticleIdList": ["10.1016/j.phymed.2022.154163", "35597027"]}, {"Citation": "Bian Z., Qin Y., Li L., Su L., Fei C., Li Y., Hu M., Chen X., Zhang W., Mao C., et al. Schisandra chinensis (Turcz.) Baill. Protects against DSS-induced colitis in mice: Involvement of TLR4/NF-\u03baB/NLRP3 inflammasome pathway and gut microbiota. J. Ethnopharmacol. 2022;298:115570. doi: 10.1016/j.jep.2022.115570.", "ArticleIdList": ["10.1016/j.jep.2022.115570", "35868549"]}, {"Citation": "Yan S., Wang P., Wei H., Jia R., Zhen M., Li Q., Xue C., Li J. Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa. Phytomedicine. 2022;105:154362. doi: 10.1016/j.phymed.2022.154362.", "ArticleIdList": ["10.1016/j.phymed.2022.154362", "35947900"]}, {"Citation": "Xue S., Xue Y., Dou D., Wu H., Zhang P., Gao Y., Tang Y., Xia Z., Yang S., Gu S. Kui Jie Tong Ameliorates Ulcerative Colitis by Regulating Gut Microbiota and NLRP3/Caspase-1 Classical Pyroptosis Signaling Pathway. Dis. Markers. 2022;2022:2782112. doi: 10.1155/2022/2782112.", "ArticleIdList": ["10.1155/2022/2782112", "PMC9273439", "35832643"]}, {"Citation": "Sudeep H.V., Venkatakrishna K., Raj A., Reethi B., Shyamprasad K. Viphyllin\u2122, a standardized extract from black pepper seeds, mitigates intestinal inflammation, oxidative stress, and anxiety-like behavior in DSS-induced colitis mice. J. Food Biochem. 2022;46:e14306. doi: 10.1111/jfbc.14306.", "ArticleIdList": ["10.1111/jfbc.14306", "35766031"]}, {"Citation": "Salama R.M., Darwish S.F., El Shaffei I., Elmongy N.F., Fahmy N.M., Afifi M.S., Abdel-Latif G.A. Morus macroura Miq. Fruit extract protects against acetic acid-induced ulcerative colitis in rats: Novel mechanistic insights on its impact on miRNA-223 and on the TNF\u03b1/NF\u03baB/NLRP3 inflammatory axis. Food Chem. Toxicol. 2022;165:113146. doi: 10.1016/j.fct.2022.113146.", "ArticleIdList": ["10.1016/j.fct.2022.113146", "35595039"]}, {"Citation": "Wang J., Wang X., Ma X., Xu B., Chen L., Chen C., Liu W., Liu Y., Xiang Z. Therapeutic effect of Patrinia villosa on TNBS-induced ulcerative colitis via metabolism, vitamin D receptor and NF-\u03baB signaling pathways. J. Ethnopharmacol. 2022;288:114989. doi: 10.1016/j.jep.2022.114989.", "ArticleIdList": ["10.1016/j.jep.2022.114989", "35032589"]}, {"Citation": "Dai W., Zhan X., Peng W., Liu X., Peng W., Mei Q., Hu X. Ficus pandurata Hance Inhibits Ulcerative Colitis and Colitis-Associated Secondary Liver Damage of Mice by Enhancing Antioxidation Activity. Oxid. Med. Cell. Longev. 2021;2021:2617881. doi: 10.1155/2021/2617881.", "ArticleIdList": ["10.1155/2021/2617881", "PMC8710911", "34966476"]}, {"Citation": "Li C., Wang M., Sui J., Zhou Y., Chen W. Protective mechanisms of Agrimonia pilosa Ledeb in dextran sodium sulfate-induced colitis as determined by a network pharmacology approach. Acta Biochim. Biophys. Sin. 2021;53:1342\u20131353. doi: 10.1093/abbs/gmab116.", "ArticleIdList": ["10.1093/abbs/gmab116", "34523667"]}, {"Citation": "Sheng K., Zhang G., Sun M., He S., Kong X., Wang J., Zhu F., Zha X., Wang Y. Grape seed proanthocyanidin extract ameliorates dextran sulfate sodium-induced colitis through intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokines and gut microbiota modulation. Food Funct. 2020;11:7817\u20137829. doi: 10.1039/D0FO01418D.", "ArticleIdList": ["10.1039/D0FO01418D", "32808642"]}, {"Citation": "Zong S., Yang L., Park H.J., Li J. Dietary intake of Lycium ruthenicum Murray ethanol extract inhibits colonic inflammation in dextran sulfate sodium-induced murine experimental colitis. Food Funct. 2020;11:2924\u20132937. doi: 10.1039/D0FO00172D.", "ArticleIdList": ["10.1039/D0FO00172D", "32285052"]}, {"Citation": "Hua L., Liang S., Zhou Y., Wu X., Cai H., Liu Z., Ou Y., Chen Y., Chen X., Yan Y., et al. Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis. Int. Immunopharmacol. 2022;113:109431. doi: 10.1016/j.intimp.2022.109431.", "ArticleIdList": ["10.1016/j.intimp.2022.109431", "36384076"]}, {"Citation": "Zhang S., Lai Q., Liu L., Yang Y., Wang J. Morroniside alleviates lipopolysaccharide-induced inflammatory and oxidative stress in inflammatory bowel disease by inhibiting NLRP3 and NF-\u03baB signaling pathways. Allergol. Immunopathol. 2022;50:93\u201399. doi: 10.15586/aei.v50i6.674.", "ArticleIdList": ["10.15586/aei.v50i6.674", "36335451"]}, {"Citation": "Li J., Xu Z., OuYang C., Wu X., Xie Y., Xie J. Protopine alleviates lipopolysaccharide-triggered intestinal epithelial cell injury through retarding the NLRP3 and NF-\u03baB signaling pathways to reduce inflammation and oxidative stress. Allergol. Immunopathol. 2022;50:84\u201392. doi: 10.15586/aei.v50i6.669.", "ArticleIdList": ["10.15586/aei.v50i6.669", "36335450"]}, {"Citation": "Yu S., Qian H., Zhang D., Jiang Z. Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP/NLRP3 pathway in rats. Cell Biol. Int. 2022;47:417\u2013427. doi: 10.1002/cbin.11935.", "ArticleIdList": ["10.1002/cbin.11935", "36251276"]}, {"Citation": "Shao M., Yan Y., Zhu F., Yang X., Qi Q., Yang F., Hao T., Lin Z., He P., Zhou Y., et al. Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis. Front. Pharmacol. 2022;13:849014. doi: 10.3389/fphar.2022.849014.", "ArticleIdList": ["10.3389/fphar.2022.849014", "PMC9477143", "36120344"]}, {"Citation": "Chen L., Liu D., Mao M., Liu W., Wang Y., Liang Y., Cao W., Zhong X. Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory Pyroptosis. Mol. Nutr. Food Res. 2022;66:e2200341. doi: 10.1002/mnfr.202200341.", "ArticleIdList": ["10.1002/mnfr.202200341", "36069237"]}, {"Citation": "Palenca I., Seguella L., Del Re A., Franzin S.B., Corpetti C., Pesce M., Rurgo S., Steardo L., Sarnelli G., Esposito G. N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-\u03b1-Dependent Mechanism. Biomolecules. 2022;12:1163. doi: 10.3390/biom12081163.", "ArticleIdList": ["10.3390/biom12081163", "PMC9405927", "36009057"]}, {"Citation": "Ruan S., Zha L. Moronic acid improves intestinal inflammation in mice with chronic colitis by inhibiting intestinal macrophage polarization. J. Biochem. Mol. Toxicol. 2022;36:e23188. doi: 10.1002/jbt.23188.", "ArticleIdList": ["10.1002/jbt.23188", "35924425"]}, {"Citation": "Ma X., Di Q., Li X., Zhao X., Zhang R., Xiao Y., Li X., Wu H., Tang H., Quan J., et al. Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3. Front. Immunol. 2022;13:853194. doi: 10.3389/fimmu.2022.853194.", "ArticleIdList": ["10.3389/fimmu.2022.853194", "PMC9296101", "35865528"]}, {"Citation": "Li X., Wu X., Wang Q., Xu W., Zhao Q., Xu N., Hu X., Ye Z., Yu S., Liu J., et al. Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice. Phytomedicine. 2022;104:154321. doi: 10.1016/j.phymed.2022.154321.", "ArticleIdList": ["10.1016/j.phymed.2022.154321", "35843190"]}, {"Citation": "Cheng J., Ma X., Zhang H., Wu X., Li M., Ai G., Zhan R., Xie J., Su Z., Huang X. 8-Oxypalmatine, a novel oxidative metabolite of palmatine, exhibits superior anti-colitis effect via regulating Nrf2 and NLRP3 inflammasome. Biomed. Pharmacother. 2022;153:113335. doi: 10.1016/j.biopha.2022.113335.", "ArticleIdList": ["10.1016/j.biopha.2022.113335", "35779424"]}, {"Citation": "Zhang H.X., Li Y.Y., Liu Z.J., Wang J.F. Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4/NF-\u03baB/NLRP3 signaling pathway in vivo and in vitro. Food Nutr. Res. 2022;66 doi: 10.29219/fnr.v66.8948.", "ArticleIdList": ["10.29219/fnr.v66.8948", "PMC9899048", "36793340"]}, {"Citation": "Yao H., Yan J., Yin L., Chen W. Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-\u03baB signaling pathway. Immunopharmacol. Immunotoxicol. 2022;44:437\u2013446. doi: 10.1080/08923973.2022.2054425.", "ArticleIdList": ["10.1080/08923973.2022.2054425", "35293848"]}, {"Citation": "Miao F. Hydroxytyrosol alleviates dextran sodium sulfate-induced colitis by inhibiting NLRP3 inflammasome activation and modulating gut microbiota in vivo. Nutrition. 2022;97:111579. doi: 10.1016/j.nut.2021.111579.", "ArticleIdList": ["10.1016/j.nut.2021.111579", "35248848"]}, {"Citation": "Pan X., Wang H., Zheng Z., Huang X., Yang L., Liu J., Wang K., Zhang Y. Pectic polysaccharide from Smilax china L. ameliorated ulcerative colitis by inhibiting the galectin-3/NLRP3 inflammasome pathway. Carbohydr. Polym. 2022;277:118864. doi: 10.1016/j.carbpol.2021.118864.", "ArticleIdList": ["10.1016/j.carbpol.2021.118864", "34893269"]}, {"Citation": "Li R., Chen C., Liu B., Shi W., Shimizu K., Zhang C. Bryodulcosigenin a natural cucurbitane-type triterpenoid attenuates dextran sulfate sodium (DSS)-induced colitis in mice. Phytomedicine. 2022;94:153814. doi: 10.1016/j.phymed.2021.153814.", "ArticleIdList": ["10.1016/j.phymed.2021.153814", "34798522"]}, {"Citation": "Cai J., Liu J., Fan P., Dong X., Zhu K., Liu X., Zhang N., Cao Y. Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation. Int. Immunopharmacol. 2021;99:108015. doi: 10.1016/j.intimp.2021.108015.", "ArticleIdList": ["10.1016/j.intimp.2021.108015", "34339962"]}, {"Citation": "Marinho S., Illanes M., \u00c1vila-Rom\u00e1n J., Motilva V., Talero E. Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome. Biomolecules. 2021;11:162. doi: 10.3390/biom11020162.", "ArticleIdList": ["10.3390/biom11020162", "PMC7912577", "33530569"]}, {"Citation": "Liang H., Cheng R., Wang J., Xie H., Li R., Shimizu K., Zhang C. Mogrol, an aglycone of mogrosides, attenuates ulcerative colitis by promoting AMPK activation. Phytomedicine. 2021;81:153427. doi: 10.1016/j.phymed.2020.153427.", "ArticleIdList": ["10.1016/j.phymed.2020.153427", "33296813"]}, {"Citation": "Qian B., Wang C., Zeng Z., Ren Y., Li D., Song J.L. Ameliorative Effect of Sinapic Acid on Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in Kunming (KM) Mice. Oxid. Med. Cell. Longev. 2020;2020:8393504. doi: 10.1155/2020/8393504.", "ArticleIdList": ["10.1155/2020/8393504", "PMC7719534", "33312339"]}, {"Citation": "Ding W., Ding Z., Wang Y., Zhu Y., Gao Q., Cao W., Du R. Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly. Front. Pharmacol. 2020;11:573870. doi: 10.3389/fphar.2020.573870.", "ArticleIdList": ["10.3389/fphar.2020.573870", "PMC7681073", "33240089"]}, {"Citation": "Pu Z., Liu Y., Li C., Xu M., Xie H., Zhao J. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling. Am. J. Chin. Med. 2020;48:1693\u20131713. doi: 10.1142/S0192415X20500846.", "ArticleIdList": ["10.1142/S0192415X20500846", "33202149"]}, {"Citation": "Zeng J., Zhang D., Wan X., Bai Y., Yuan C., Wang T., Yuan D., Zhang C., Liu C. Chlorogenic Acid Suppresses miR-155 and Ameliorates Ulcerative Colitis through the NF-\u03baB/NLRP3 Inflammasome Pathway. Mol. Nutr. Food Res. 2020;64:e2000452. doi: 10.1002/mnfr.202000452.", "ArticleIdList": ["10.1002/mnfr.202000452", "33078870"]}, {"Citation": "Sun H., Cai H., Fu Y., Wang Q., Ji K., Du L., Xu C., Tian L., He N., Wang J., et al. The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice. Dose Response. 2020;18:1559325820931292. doi: 10.1177/1559325820931292.", "ArticleIdList": ["10.1177/1559325820931292", "PMC7323307", "32636719"]}, {"Citation": "Tian M., Ma P., Zhang Y., Mi Y., Fan D. Ginsenoside Rk3 alleviated DSS-induced ulcerative colitis by protecting colon barrier and inhibiting NLRP3 inflammasome pathway. Int. Immunopharmacol. 2020;85:106645. doi: 10.1016/j.intimp.2020.106645.", "ArticleIdList": ["10.1016/j.intimp.2020.106645", "32521491"]}, {"Citation": "Zhang Q., Xu N., Hu X., Zheng Y. Anti-colitic effects of Physalin B on dextran sodium sulfate-induced BALB/c mice by suppressing multiple inflammatory signaling pathways. J. Ethnopharmacol. 2020;259:112956. doi: 10.1016/j.jep.2020.112956.", "ArticleIdList": ["10.1016/j.jep.2020.112956", "32442587"]}, {"Citation": "Liu Q., Zuo R., Wang K., Nong F.F., Fu Y.J., Huang S.W., Pan Z.F., Zhang Y., Luo X., Deng X.L., et al. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-\u03baB pathway. Acta Pharmacol. Sin. 2020;41:771\u2013781. doi: 10.1038/s41401-019-0335-4.", "ArticleIdList": ["10.1038/s41401-019-0335-4", "PMC7468572", "31937929"]}, {"Citation": "Chen Y., Zheng Z., Li C., Pan Y., Tang X., Wang X.J. Synthetic Imine Resveratrol Analog 2-Methoxyl-3,6-Dihydroxyl-IRA Ameliorates Colitis by Activating Protective Nrf2 Pathway and Inhibiting NLRP3 Expression. Oxid. Med. Cell. Longev. 2019;2019:7180284. doi: 10.1155/2019/7180284.", "ArticleIdList": ["10.1155/2019/7180284", "PMC6914940", "31885813"]}, {"Citation": "Gong Z., Zhao S., Zhou J., Yan J., Wang L., Du X., Li H., Chen Y., Cai W., Wu J. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1\u03b2 production. Mol. Immunol. 2018;104:11\u201319. doi: 10.1016/j.molimm.2018.09.004.", "ArticleIdList": ["10.1016/j.molimm.2018.09.004", "30396035"]}, {"Citation": "Liu X., Zhou W., Zhang X., Lu P., Du Q., Tao L., Ding Y., Wang Y., Hu R. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. Biochem. Pharmacol. 2016;112:37\u201349. doi: 10.1016/j.bcp.2016.05.002.", "ArticleIdList": ["10.1016/j.bcp.2016.05.002", "27184504"]}, {"Citation": "Kevans D., Silverberg M.S., Borowski K., Griffiths A., Xu W., Onay V., Paterson A.D., Knight J., Croitoru K. IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn\u2019s Disease Patients. J. Crohns Colitis. 2016;10:209\u2013215. doi: 10.1093/ecco-jcc/jjv197.", "ArticleIdList": ["10.1093/ecco-jcc/jjv197", "PMC5007582", "26512135"]}, {"Citation": "Aniwan S., Santiago P., Loftus Jr E.V., Park S.H. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur. Gastroenterol. J. 2022;10:1063\u20131076. doi: 10.1002/ueg2.12350.", "ArticleIdList": ["10.1002/ueg2.12350", "PMC9752270", "36479863"]}, {"Citation": "Du L., Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol. Clin. N. Am. 2020;49:643\u2013654. doi: 10.1016/j.gtc.2020.07.005.", "ArticleIdList": ["10.1016/j.gtc.2020.07.005", "33121686"]}, {"Citation": "Kaenkumchorn T., Wahbeh G. Ulcerative Colitis: Making the Diagnosis. Gastroenterol. Clin. N. Am. 2020;49:655\u2013669. doi: 10.1016/j.gtc.2020.07.001.", "ArticleIdList": ["10.1016/j.gtc.2020.07.001", "33121687"]}, {"Citation": "Adams S.M., Bornemann P.H. Ulcerative colitis. Am. Fam. Physician. 2013;87:699\u2013705.", "ArticleIdList": ["23939448"]}, {"Citation": "Keshteli A.H., Madsen K.L., Dieleman L.A. Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions. Nutrients. 2019;11:1498. doi: 10.3390/nu11071498.", "ArticleIdList": ["10.3390/nu11071498", "PMC6683258", "31262022"]}, {"Citation": "Ord\u00e1s I., Eckmann L., Talamini M., Baumgart D.C., Sandborn W.J. Ulcerative colitis. Lancet. 2012;380:1606\u20131619. doi: 10.1016/S0140-6736(12)60150-0.", "ArticleIdList": ["10.1016/S0140-6736(12)60150-0", "22914296"]}, {"Citation": "Niv Y. Hospitalization of Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis. Isr. Med. Assoc. J. 2021;23:186\u2013190.", "ArticleIdList": ["33734633"]}, {"Citation": "Lee S.D. Health Maintenance in Ulcerative Colitis. Gastroenterol. Clin. N. Am. 2020;49:xv\u2013xvi. doi: 10.1016/j.gtc.2020.09.002.", "ArticleIdList": ["10.1016/j.gtc.2020.09.002", "33121699"]}, {"Citation": "Segal J.P., LeBlanc J.F., Hart A.L. Ulcerative colitis: An update. Clin. Med. 2021;21:135\u2013139. doi: 10.7861/clinmed.2021-0080.", "ArticleIdList": ["10.7861/clinmed.2021-0080", "PMC8002778", "33762374"]}, {"Citation": "Roselli M., Finamore A. Use of Synbiotics for Ulcerative Colitis Treatment. Curr. Clin. Pharmacol. 2020;15:174\u2013182. doi: 10.2174/1574884715666191226120322.", "ArticleIdList": ["10.2174/1574884715666191226120322", "31878863"]}, {"Citation": "Sun Y., Zhang Z., Zheng C.Q., Sang L.X. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J. Gastroenterol. 2021;27:2963\u20132978. doi: 10.3748/wjg.v27.i22.2963.", "ArticleIdList": ["10.3748/wjg.v27.i22.2963", "PMC8192286", "34168401"]}, {"Citation": "Wehkamp J., Stange E.F. Recent advances and emerging therapies in the non-surgical management of ulcerative colitis. F1000Research. 2018;7:1207. doi: 10.12688/f1000research.15159.1.", "ArticleIdList": ["10.12688/f1000research.15159.1", "PMC6081982", "30135722"]}, {"Citation": "Hashash J.G., Picco M.F., Farraye F.A. Health Maintenance for Adult Patients with Inflammatory Bowel Disease. Curr. Treat. Options Gastroenterol. 2021;19:583\u2013596. doi: 10.1007/s11938-021-00364-9.", "ArticleIdList": ["10.1007/s11938-021-00364-9", "PMC8608358", "34840495"]}, {"Citation": "Louis E. Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease. Front. Med. 2019;6:302. doi: 10.3389/fmed.2019.00302.", "ArticleIdList": ["10.3389/fmed.2019.00302", "PMC6960136", "31970158"]}, {"Citation": "Carter M.J., Lobo A.J., Travis S.P.L. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53:v1. doi: 10.1136/gut.2004.043372.", "ArticleIdList": ["10.1136/gut.2004.043372", "PMC1867788", "15306569"]}, {"Citation": "Louis E. Stopping Anti-TNF in Crohn\u2019s Disease Remitters: Pros and Cons: The Pros. Inflamm. Intest. Dis. 2022;7:64\u201368. doi: 10.1159/000520942.", "ArticleIdList": ["10.1159/000520942", "PMC8820144", "35224020"]}, {"Citation": "Petagna L., Antonelli A., Ganini C., Bellato V., Campanelli M., Divizia A., Efrati C., Franceschilli M., Guida A.M., Ingallinella S., et al. Pathophysiology of Crohn\u2019s disease inflammation and recurrence. Biol. Direct. 2020;15:23. doi: 10.1186/s13062-020-00280-5.", "ArticleIdList": ["10.1186/s13062-020-00280-5", "PMC7648997", "33160400"]}, {"Citation": "Veauthier B., Hornecker J.R. Crohn\u2019s Disease: Diagnosis and Management. Am. Fam. Physician. 2018;98:661\u2013669.", "ArticleIdList": ["30485038"]}, {"Citation": "Yang F., Ni B., Liu Q., He F., Li L., Zhong X., Zheng X., Lu J., Chen X., Lin H., et al. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota. Stem Cell Res. Ther. 2022;13:475. doi: 10.1186/s13287-022-03118-1.", "ArticleIdList": ["10.1186/s13287-022-03118-1", "PMC9476645", "36104756"]}, {"Citation": "Torres J., Burisch J., Riddle M., Dubinsky M., Colombel J.F. Preclinical disease and preventive strategies in IBD: Perspectives, challenges and opportunities. Gut. 2016;65:1061\u20131069. doi: 10.1136/gutjnl-2016-311785.", "ArticleIdList": ["10.1136/gutjnl-2016-311785", "27196600"]}, {"Citation": "Nadalian B., Nadalian B., Houri H., Shahrokh S., Abdehagh M., Yadegar A., Ebrahimipour G. Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran. Front. Med. 2022;9:985300. doi: 10.3389/fmed.2022.985300.", "ArticleIdList": ["10.3389/fmed.2022.985300", "PMC9464868", "36106322"]}, {"Citation": "Atanassova A., Georgieva A. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations\u2014A cohort study in Bulgarian patients. Eur. Rev. Med. Pharmacol. Sci. 2022;26:6310\u20136315. doi: 10.26355/eurrev_202209_29655.", "ArticleIdList": ["10.26355/eurrev_202209_29655", "36111932"]}, {"Citation": "Shahini A., Shahini A. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: Focus on the available therapeutic approaches and gut microbiome. J. Cell Commun. Signal. 2022;17:55\u201374. doi: 10.1007/s12079-022-00695-x.", "ArticleIdList": ["10.1007/s12079-022-00695-x", "PMC10030733", "36112307"]}, {"Citation": "Zhao X., Yang W., Yu T., Yu Y., Cui X., Zhou Z., Yang H., Yu Y., Bilotta A.J., Yao S., et al. Th17 cell-derived amphiregulin promotes colitis-associated intestinal fibrosis through activation of mTOR and MEK in intestinal myofibroblasts. Gastroenterology. 2022;164:89\u2013102. doi: 10.1053/j.gastro.2022.09.006.", "ArticleIdList": ["10.1053/j.gastro.2022.09.006", "PMC9772145", "36113570"]}, {"Citation": "Askari H., Shojaei-Zarghani S., Raeis-Abdollahi E., Jahromi H.K., Abdullahi P.R., Daliri K., Tajbakhsh A., Rahmati L., Safarpour A.R. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art. Mini Rev. Med. Chem. 2022 doi: 10.2174/1389557522666220914093331.", "ArticleIdList": ["10.2174/1389557522666220914093331", "36111766"]}, {"Citation": "Boix-Amor\u00f3s A., Monaco H., Sambataro E., Clemente J.C. Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease. Gut Microbes. 2022;14:2107866. doi: 10.1080/19490976.2022.2107866.", "ArticleIdList": ["10.1080/19490976.2022.2107866", "PMC9481095", "36104776"]}, {"Citation": "Yang J., Wise L., Fukuchi K.I. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer\u2019s Disease. Front. Immunol. 2020;11:724. doi: 10.3389/fimmu.2020.00724.", "ArticleIdList": ["10.3389/fimmu.2020.00724", "PMC7190872", "32391019"]}, {"Citation": "Wang L., Hauenstein A.V. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Mol. Asp. Med. 2020;76:100889. doi: 10.1016/j.mam.2020.100889.", "ArticleIdList": ["10.1016/j.mam.2020.100889", "32859386"]}, {"Citation": "Silveira Rossi J.L., Barbalho S.M., Reverete de Araujo R., Bechara M.D., Sloan K.P., Sloan L.A. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes/Metab. Res. Rev. 2022;38:e3502. doi: 10.1002/dmrr.3502.", "ArticleIdList": ["10.1002/dmrr.3502", "34614543"]}, {"Citation": "Jo E.K., Kim J.K., Shin D.M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 2016;13:148\u2013159. doi: 10.1038/cmi.2015.95.", "ArticleIdList": ["10.1038/cmi.2015.95", "PMC4786634", "26549800"]}, {"Citation": "Chen M.Y., Ye X.J., He X.H., Ouyang D.Y. The Signaling Pathways Regulating NLRP3 Inflammasome Activation. Inflammation. 2021;44:1229\u20131245. doi: 10.1007/s10753-021-01439-6.", "ArticleIdList": ["10.1007/s10753-021-01439-6", "34009550"]}, {"Citation": "Chen Q.L., Yin H.R., He Q.Y., Wang Y. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed. Pharmacother. 2021;138:111442. doi: 10.1016/j.biopha.2021.111442.", "ArticleIdList": ["10.1016/j.biopha.2021.111442", "33667791"]}, {"Citation": "Shao B.Z., Wang S.L., Pan P., Yao J., Wu K., Li Z.S., Bai Y., Linghu E.Q. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation. Inflammation. 2019;42:1147\u20131159. doi: 10.1007/s10753-019-01008-y.", "ArticleIdList": ["10.1007/s10753-019-01008-y", "30937839"]}, {"Citation": "Zhou W., Liu X., Zhang X., Tang J., Li Z., Wang Q., Hu R. Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. Oncotarget. 2017;8:58903\u201358917. doi: 10.18632/oncotarget.19440.", "ArticleIdList": ["10.18632/oncotarget.19440", "PMC5601702", "28938606"]}, {"Citation": "Sun Y., Zhao Y., Yao J., Zhao L., Wu Z., Wang Y., Pan D., Miao H., Guo Q., Lu N. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-\u03baB and NLRP3 inflammasome activation. Biochem. Pharmacol. 2015;94:142\u2013154. doi: 10.1016/j.bcp.2015.02.002.", "ArticleIdList": ["10.1016/j.bcp.2015.02.002", "25677765"]}, {"Citation": "Liu W., Guo W., Hang N., Yang Y., Wu X., Shen Y., Cao J., Sun Y., Xu Q. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-\u03baB and NLRP3 inflammasome activation. Oncotarget. 2016;7:30536\u201330549. doi: 10.18632/oncotarget.8867.", "ArticleIdList": ["10.18632/oncotarget.8867", "PMC5058699", "27105502"]}, {"Citation": "Zhang C., Qin J., Zhang S., Zhang N., Tan B., Siwko S., Zhang Y., Wang Q., Chen J., Qian M., et al. ADP/P2Y(1) aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation. Mucosal Immunol. 2020;13:931\u2013945. doi: 10.1038/s41385-020-0307-5.", "ArticleIdList": ["10.1038/s41385-020-0307-5", "32518369"]}, {"Citation": "Wang M., Jiang F., Zhang L., Zhang J., Xie H. Knockdown of P2Y4 ameliorates sepsis-induced acute kidney injury in mice via inhibiting the activation of the NF-\u03baB/MMP8 axis. Front. Physiol. 2022;13:953977. doi: 10.3389/fphys.2022.953977.", "ArticleIdList": ["10.3389/fphys.2022.953977", "PMC9467379", "36105291"]}, {"Citation": "Liang B., Wu C., Wang C., Sun W., Chen W., Hu X., Liu N., Xing D. New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease. Front. Microbiol. 2022;13:1065608. doi: 10.3389/fmicb.2022.1065608.", "ArticleIdList": ["10.3389/fmicb.2022.1065608", "PMC9802581", "36590401"]}, {"Citation": "Zhou L., Liu T., Huang B., Luo M., Chen Z., Zhao Z., Wang J., Leung D., Yang X., Chan K.W., et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J. Allergy Clin. Immunol. 2021;147:267\u2013279. doi: 10.1016/j.jaci.2020.09.003.", "ArticleIdList": ["10.1016/j.jaci.2020.09.003", "32941940"]}, {"Citation": "Rao Z., Chen X., Wu J., Xiao M., Zhang J., Wang B., Fang L., Zhang H., Wang X., Yang S., et al. Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination. Front. Immunol. 2019;10:2783. doi: 10.3389/fimmu.2019.02783.", "ArticleIdList": ["10.3389/fimmu.2019.02783", "PMC6904361", "31866999"]}, {"Citation": "Ngui I.Q.H., Perera A.P., Eri R. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer? Molecules. 2020;25:2427. doi: 10.3390/molecules25102427.", "ArticleIdList": ["10.3390/molecules25102427", "PMC7287590", "32456012"]}, {"Citation": "Chen X., Liu G., Yuan Y., Wu G., Wang S., Yuan L. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling. Cell Death Dis. 2019;10:906. doi: 10.1038/s41419-019-2157-1.", "ArticleIdList": ["10.1038/s41419-019-2157-1", "PMC6885517", "31787755"]}, {"Citation": "Song Y., Zhao Y., Ma Y., Wang Z., Rong L., Wang B., Zhang N. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev. 2021;60:61\u201375. doi: 10.1016/j.cytogfr.2021.03.003.", "ArticleIdList": ["10.1016/j.cytogfr.2021.03.003", "33773897"]}, {"Citation": "Li N., Wang M., Lyu Z., Shan K., Chen Z., Chen B., Chen Y., Hu X., Dou B., Zhang J., et al. Medicinal plant-based drug delivery system for inflammatory bowel disease. Front. Pharmacol. 2023;14:1158945. doi: 10.3389/fphar.2023.1158945.", "ArticleIdList": ["10.3389/fphar.2023.1158945", "PMC10076537", "37033644"]}, {"Citation": "Ning L., Ye N., Ye B., Miao Z., Cao T., Lu W., Xu D., Tan C., Xu Y., Yan J. Qingre Xingyu recipe exerts inhibiting effects on ulcerative colitis development by inhibiting TNF\u03b1/NLRP3/Caspase-1/IL-1\u03b2 pathway and macrophage M1 polarization. Cell Death Discov. 2023;9:84. doi: 10.1038/s41420-023-01361-w.", "ArticleIdList": ["10.1038/s41420-023-01361-w", "PMC9995513", "36890151"]}, {"Citation": "Chen X., Gao Y., Xie J., Hua H., Pan C., Huang J., Jing M., Chen X., Xu C., Gao Y., et al. Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases. J. Transl. Med. 2023;21:203. doi: 10.1186/s12967-023-04038-1.", "ArticleIdList": ["10.1186/s12967-023-04038-1", "PMC10022188", "36932401"]}, {"Citation": "Chen J., Pan M., Wang J., Zhang M., Feng M., Chai X., Zhang Q., Sun Y. Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. Toxicol. Appl. Pharmacol. 2023;467:116494. doi: 10.1016/j.taap.2023.116494.", "ArticleIdList": ["10.1016/j.taap.2023.116494", "37001609"]}, {"Citation": "Thorn J.P.R., Thornton T.F., Helfgott A., Willis K.J. Indigenous uses of wild and tended plant biodiversity maintain ecosystem services in agricultural landscapes of the Terai Plains of Nepal. J. Ethnobiol. Ethnomed. 2020;16:33. doi: 10.1186/s13002-020-00382-4.", "ArticleIdList": ["10.1186/s13002-020-00382-4", "PMC7278186", "32513199"]}, {"Citation": "Constant N.L., Tshisikhawe M.P. Hierarchies of knowledge: Ethnobotanical knowledge, practices and beliefs of the Vhavenda in South Africa for biodiversity conservation. J. Ethnobiol. Ethnomed. 2018;14:56. doi: 10.1186/s13002-018-0255-2.", "ArticleIdList": ["10.1186/s13002-018-0255-2", "PMC6108143", "30139359"]}, {"Citation": "Maroyi A. Diversity of use and local knowledge of wild and cultivated plants in the Eastern Cape province, South Africa. J. Ethnobiol. Ethnomed. 2017;13:43. doi: 10.1186/s13002-017-0173-8.", "ArticleIdList": ["10.1186/s13002-017-0173-8", "PMC5549312", "28789692"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "17"}, {"Year": "2023", "Month": "6", "Day": "3"}, {"Year": "2023", "Month": "6", "Day": "5"}, {"Year": "2023", "Month": "6", "Day": "27", "Hour": "13", "Minute": "11"}, {"Year": "2023", "Month": "6", "Day": "27", "Hour": "13", "Minute": "10"}, {"Year": "2023", "Month": "6", "Day": "27", "Hour": "10", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["37367886", "PMC10305268", "10.3390/metabo13060728", "metabo13060728"]}}], "PubmedBookArticle": []}